A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer

Physics in Medicine and Biology

Volumn 59, Issue 16, 2014, Pages 4697-4722

  Joosten, A ^a,b   Bochud, F ^a   Moeckli, R ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

monte carlo; risk models; secondary cancer

Indexed keywords

DISEASES; IONIZING RADIATION; MONTE CARLO METHODS; PHYSICAL THERAPY; RADIOTHERAPY; RISK PERCEPTION;

BIOLOGICAL EFFECTS OF IONIZING RADIATIONS; COMPREHENSIVE EVALUATION; CONTRALATERAL BREAST; INTENSITY MODULATED RADIATION THERAPY; INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTIONS; RISK MODEL; SECONDARY CANCER; SECONDARY CANCER RISK;

RISK ASSESSMENT;

ADVERSE EFFECTS; BREAST NEOPLASMS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE QUALITY; INTENSITY MODULATED RADIATION THERAPY; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; NONLINEAR SYSTEM; RADIATION DOSE; RADIATION PROTECTION; RADIOGRAPHY; RISK ASSESSMENT; STATISTICAL MODEL; WHOLE BODY IMAGING;

BREAST NEOPLASMS; HUMANS; LINEAR MODELS; MODELS, STATISTICAL; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; NONLINEAR DYNAMICS; PHANTOMS, IMAGING; RADIATION DOSAGE; RADIATION PROTECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 84905694243     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/59/16/4697     Document Type: Article

References (77)

1. Alvarez Moret J, Koelbl O and Bogner L 2009 Quasi-IMAT technique and secondary cancer risk in prostate cancer Strahlenther. Onkol 185 248-53
2. Athar B S and Paganetti H 2011 Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans Radiother. Oncol 98 87-92
3. Bednarz B, Athar B and Xu X G 2010 A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models Med. Phys 37 1987-94
4. Berrington de G A, Curtis R E, Gilbert E, Berg C D, Smith S A, Stovall M and Ron E 2010 Second solid cancers after radiotherapy for breast cancer in SEER cancer registries Br. J. Cancer 102 220-6
5. Berrington de Gonzalez A, Gilbert E, Curtis R, Inskip P, Kleinerman R, Morton L, Rajaraman P and Little M P 2013 Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship Int. J. Radiat. Oncol. Biol. Phys 86 224-33
6. Blyth B J and Sykes P J 2011 Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures? Radiat. Res 176 139-57
7. Boice J D Jr et al 1987 Radiation dose and leukemia risk in patients treated for cancer of the cervix J. Natl. Cancer Inst 79 1295-311
8. Brown L M et al 2007 Risk of second non-hematological malignancies among 376,825 breast cancer survivors Breast Cancer Res. Treat 106 439-51 (Pubitemid 350029686)
9. Clarke M et al 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087-106 (Pubitemid 41797643)
10. Curtis R E et al 1992 Risk of leukemia after chemotherapy and radiation treatment for breast cancer N. Engl. J. Med 326 1745-51
11. Curtis R E, Boice J D Jr, Stovall M, Flannery J T and Moloney W C 1989 Leukemia risk following radiotherapy for breast cancer J. Clin. Oncol 7 21-9 (Pubitemid 19089077)
12. Dasu A, Toma-Dasu I, Olofsson J and Karlsson M 2005 The use of risk estimation models for the induction of secondary cancers following radiotherapy Acta Oncol 44 339-47 (Pubitemid 41021038)
13. Diallo I et al 2009 Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer Int. J Radiat. Oncol. Biol. Phys 74 876-83
14. Donovan E M, James H, Bonora M, Yarnold J R and Evans P M 2012 Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer Med. Phys 39 5814-24
15. Fletcher G H 1980 Textbook of Radiotherapy
16. Followill D, Geis P and Boyer A 1997 Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy Int. J. Radiat. Oncol. Biol. Phys 38 667-72 (Pubitemid 27305029)
17. Fontenot J D, Bloch C, Followill D, Titt U and Newhauser W D 2010 Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy Phys. Med. Biol 55 6987-98
18. Fontenot J D, Lee A K and Newhauser W D 2009 Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer Int. J. Radiat. Oncol. Biol. Phys 74 616-22
19. Gilbert E S et al 2003 Lung cancer after treatment for Hodgkin's disease: focus on radiation effects Radiat. Res 159 161-73 (Pubitemid 36182394)
20. Hall E J 2006 Intensity-modulated radiation therapy, protons, and the risk of second cancers Int. J. Radiat. Oncol. Biol. Phys 65 1-7
21. Hall E J, Martin S G, Amols H and Hei T K 1995 Photoneutrons from medical linear accelerators-radiobiological measurements and risk estimates Int. J. Radiat. Oncol. Biol. Phys 33 225-30
22. Hall E J and Wuu C S 2003 Radiation-induced second cancers: the impact of 3D-CRT and IMRT Int. J. Radiat. Oncol. Biol. Phys 56 83-88 (Pubitemid 36403679)
23. Harvey E B and Brinton L A 1985 Second cancer following cancer of the breast in Connecticut, 1935-82 Natl. Cancer Inst. Monogr 68 99-112 (Pubitemid 16233726)
24. Hodgson D C et al 2007 Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma Cancer 110 2576-86 (Pubitemid 350174945)
25. Hooning M J, Aleman B M, Hauptmann M, Baaijens M H, Klijn J G, Noyon R, Stovall M and van Leeuwen F E 2008 Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer J. Clin. Oncol 26 5561-8
26. Hussein M, Aldridge S, Guerrero Urbano T and Nisbet A 2012 The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies Br. J. Radiol 85 423-32
27. - 1990 Recommendations of the ICRP ICRP Publication 60 (Oxford:: Elsevier)
28. - 1996 Basic anatomical & physiological data fur use in radiological protection: the skeleton ICRP Publication 70 (Oxford: Elsevier)
29. - 2008 Recommendations of the ICRP ICRP Publication 103 (Oxford: Elsevier)
30. Johansen S, Cozzi L and Olsen D R 2009 A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques Acta Oncol 48 495-503
31. Johansen S, Danielsen T and Olsen D R 2008 Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer Acta Oncol 47 391-6 (Pubitemid 351414937)
32. Joiner M C and van der Kogel A 2009 Basic Clinical Radiobiology
33. Joosten A, Bochud F, Baechler S, Levi F, Mirimanoff R O and Moeckli R 2011 Variability of a peripheral dose among various linac geometries for second cancer risk assessment Phys. Med Biol 56 5131-51
34. Joosten A, Matzinger O, Jeanneret-Sozzi W, Bochud F and Moeckli R 2013 Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment Radiother. Oncol 106 33-41
35. Karlsson P, Holmberg E, Samuelsson A, Johansson K A and Wallgren A 1998 Soft tissue sarcoma after treatment for breast cancer - a Swedish population-based study Eur. J. Cancer 34 2068-75 (Pubitemid 28546944)
36. Kirova Y M, Vilcoq J R, Asselain B, Sastre-Garau X and Fourquet A 2005 Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review Cancer 104 856-63 (Pubitemid 41113688)
37. Koh E S et al 2007 A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk Radiat. Oncol 2 13
38. Kry S F, Followill D, White R A, Stovall M, Kuban D A and Salehpour M 2007 Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy Int. J. Radiat. Oncol. Biol. Phys 68 1265-71 (Pubitemid 47048597)
39. Kry S F, Salehpour M, Followill D S, Stovall M, Kuban D A, White R A and Rosen I I 2005 The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy Int. J. Radiat. Oncol. Biol. Phys 62 1195-203 (Pubitemid 40884435)
40. Kry S F, Salehpour M, Titt U, White R A, Stovall M and Followill D 2009 Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy Radiother. Oncol 91 132-137
41. Mellemkjaer L et al 2006 Risk of second cancer among women with breast cancer Int. J. Cancer 118 2285-92
42. Mu X, Bjork-Eriksson T, Nill S, Oelfke U, Johansson K A, Gagliardi G, Johansson L, Karlsson M and Zackrisson D B 2005 Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study Acta Oncol 44 554-62 (Pubitemid 41503601)
43. Mutic S and Low D A 1998 Whole-body dose from tomotherapy delivery Int. J. Radiat. Oncol. Biol. Phys 42 229-32 (Pubitemid 28435617)
44. - 1993 Limitation of Exposure to Ionizing Radiation. Report 116 (Bethesda, MD: NCRP)
45. Neglia J P et al 2006 New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study J. Natl Cancer Inst 98 1528-37 (Pubitemid 44680904)
46. Newhauser W D and Durante M 2011 Assessing the risk of second malignancies after modern radiotherapy Nat. Rev. Cancer 11 438-48
47. - 2006 Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII - Phase 2 report (Washington, DC: The National Academies Press)
48. Obedian E, Fischer D B and Haffty B G 2000 Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy J. Clin. Oncol 18 2406-12 (PMID: 10856100) (Pubitemid 30415827)
49. Pisaturo O, Moeckli R, Mirimanoff R O and Bochud F O 2009 A Monte Carlo-based procedure for independent monitor unit calculation in IMRT treatment plans Phys. Med. Biol 54 4299-310
50. Preston D L, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K and Kodama K 2007 Solid cancer incidence in atomic bomb survivors: 1958-1998 Radiat. Res 168 1-64 (Pubitemid 351292925)
51. Preston D L, Shimizu Y, Pierce D A, Suyama A and Mabuchi K 2003 Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997 Radiat. Res 160 381-407 (Pubitemid 37174507)
52. Ronckers C M et al 2006 Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers Radiat. Res 166 618-28 (Pubitemid 44477715)
53. Roychoudhuri R, Evans H, Robinson D and Moller H 2004 Radiation-induced malignancies following radiotherapy for breast cancer Br. J. Cancer 91 868-72 (Pubitemid 39273777)
54. Ruben J D, Davis S, Evans C, Jones P, Gagliardi F, Haynes M and Hunter A 2008 The effect of intensity-modulated radiotherapy on radiation-induced second malignancies Int. J. Radiat. Oncol. Biol. Phys 70 1530-6
55. Rubino C, Shamsaldin A, Le M G, Labbe M, Guinebretiere J M, Chavaudra J and de Vathaire F 2005 Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment Breast Cancer Res. Treat 89 277-88 (Pubitemid 43293076)
56. Sachs R K and Brenner D J 2005 Solid tumor risks after high doses of ionizing radiation Proc. Natl Acad. Sci.US A 102 13040-5 (Pubitemid 41324975)
57. Schneider U 2009 Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula Med. Phys 36 1138-43
58. Schneider U and Kaser-Hotz B 2005 Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships Radiat. Environ. Biophys 44 235-9 (Pubitemid 41677231)
59. Schneider U, Lomax A, Besserer J, Pemler P, Lombriser N and Kaser-Hotz B 2007 The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer Int. J. Radiat. Oncol. Biol. Phys 68 892-7 (Pubitemid 46818764)
60. Schneider U, Lomax A and Lombriser N 2000 Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation Radiat. Res 154 382-8
61. Schneider U, Lomax A, Pemler P, Besserer J, Ross D, Lombriser N and Kaser-Hotz B 2006 The impact of IMRT and proton radiotherapy on secondary cancer incidence Strahlenther. Onkol 182 647-52 (Pubitemid 44657651)
62. Schneider U, Lomax A and Timmermann B 2008 Second cancers in children treated with modern radiotherapy techniques Radiother. Oncol 89 135-40
63. Schneider U and Schafer B 2012 Model of accelerated carcinogenesis based on proliferative stress and inflammation for doses relevant to radiotherapy Radiat. Environ. Biophys 51 451-6
64. Schneider U, Stipper A and Besserer J 2010 Dose-response relationship for lung cancer induction at radiotherapy dose Z. Med. Phys 20 206-14
65. Schneider U, Sumila M, Robotka J, Gruber G, Mack A and Besserer J 2011 Dose-response relationship for breast cancer induction at radiotherapy dose Radiat. Oncol 6 67
66. Schneider U, Zwahlen D, Ross D and Kaser-Hotz B 2005 Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose Int. J. Radiat. Oncol. Biol. Phys 61 1510-5 (Pubitemid 40470435)
67. Stathakis S, Li J and Ma C C 2007 Monte Carlo determination of radiation-induced cancer risks for prostate IMRT patients J. Appl. Clin. Med. Phys 8 14-27
68. Stathakis S, Roland T, Papanikolaou N, Li J and Ma C 2009 A prediction study on radiation-induced second malignancies for IMRT treatment delivery Technol. Cancer Res. Treat 8 141-8
69. Taddei P J, Howell R M, Krishnan S, Scarboro S B, Mirkovic D and Newhauser W D 2010 Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma Phys. Med. Biol 55 7055-65
70. Travis L B 2006 The epidemiology of second primary cancers Cancer Epidemiol. Biomarkers Prev 15 2020-6 (Pubitemid 44883051)
71. Travis L B et al 2003 Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAM A 290 465-75 (Pubitemid 37430500)
72. Unscear 2006 UNSCEAR 2006 Report Vol. I: Effects of Ionizing Radiation (New York: United Nations)
73. van Leeuwen F E et al 2003 Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease J. Natl Cancer Inst 95 971-80
74. Verellen D and Vanhavere F 1999 Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region Radiother. Oncol 53 199-203
75. Weber D C, Johanson S, Peguret N, Cozzi L and Olsen D R 2011 Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients Int. J. Radiat. Oncol. Biol. Phys 81 490-7
76. Zwahlen D R, Martin J M, Millar J L and Schneider U 2008 Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma Int. J. Radiat. Oncol. Biol. Phys 70 853-858
77. Zwahlen D R, Ruben J D, Jones P, Gagliardi F, Millar J L and Schneider U 2009 Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer Int. J. Radiat. Oncol. Biol. Phys 74 539-545